JoVE Journal
Cancer Research
Cancer Research
A subscription to JoVE is required to view this content.
Chapters
Summary
Here, we present a protocol to produce a bispecific antibody GPC3-S-Fab in Escherichia coli. The purified GPC3-S-Fab has potent cytotoxicity against GPC3 positive liver cancer cells.